| Financial Year |
March 31 2023 |
| Monetary Funds |
5,141,730,204.29 |
| Held-for-trading Financial Assets |
4,361,823.72 |
| Notes Receivable |
117,424,274.86 |
| Accounts Receivable |
6,104,194,934.79 |
| Advances to Suppliers |
2,030,762,847.96 |
| Other Receivables |
463,615,158.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,050,464.23 |
| Dividend Receivable |
-- |
| Inventories |
7,513,055,981.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
454,640,582.64 |
| Total Current Assets |
22,920,779,660.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,996,131,076.13 |
| Investment Properties |
247,744,179.49 |
| Fixed Assetes |
3,618,794,275.39 |
| Under-construction Projects |
4,403,064,789.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
890,103,989.22 |
| R&D expenses |
13,145,355.83 |
| Goodwill |
345,157,150.22 |
| Long-Term Deferred and Prepaid Expenses |
1,080,807.62 |
| Deferred Income Tax Assets |
326,521,393.98 |
| Other Non-Current Assets |
585,829,174.12 |
| Sub-Total of Non-Current Assets |
14,446,904,629.26 |
| Total Assets |
37,367,684,289.76 |
| Short-Term Loans |
9,753,181,212.14 |
| Trading Financial liabilities |
121,475,087.75 |
| Notes Payable |
630,000,000.00 |
| Accounts Payable |
2,402,717,022.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
290,826,986.46 |
| Taxes Payable |
258,369,019.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
263,206,515.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,883,178,370.99 |
| Other Current Liabilities |
126,337,874.79 |
| Sub-Total of Current Liabilities |
16,065,596,897.97 |
| Long-term Loans |
4,448,459,426.53 |
| Bonds Payable |
2,550,459,647.62 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
223,729,230.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,550,119,937.60 |
| Total Liabilities |
23,615,716,835.57 |
| Paid-In Capital(Or Share Stock) |
1,986,461,619.00 |
| Capital Surplus |
2,782,763,061.37 |
| Surplus Reserve |
345,884,807.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,350,167,328.06 |
| Minority Stockholder's Interest |
664,813,136.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,087,154,317.84 |
| Owner's Equity（Stockholder's Equity） |
13,751,967,454.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,367,684,289.76 |
